Executive record

Christopher Kenney

Chief Medical Officer at Xenon Pharmaceuticals Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:christopher-kenneyVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims2 sources
  • Executive

Key Claims

Biography

Christopher Kenney serves as Chief Medical Officer of Xenon Pharmaceuticals Inc. He entered into an amended and restated employment agreement effective February 25, 2026.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Medical Officer · Xenon Pharmaceuticals Inc.
  2. 2026 to end not publishedExecutive title: Chief Medical Officer · Organization not publishedXENE 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Apr 22, 2026 · Retrieved: Sep 14, 2026

    Supports 2 claims
    • Professional Role: Chief Medical Officer at Xenon Pharmaceuticals Inc. · Claim reviewed: Sep 14, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: Sep 14, 2026

  2. XENE 10-K executive officers

    sec filing · Source published: Feb 26, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Xenon Pharmaceuticals · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: Sep 14, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026